These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 27166271)
21. The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers. Izar B; Sequist L; Lee M; Muzikansky A; Heist R; Iafrate J; Dias-Santagata D; Mathisen D; Lanuti M Ann Thorac Surg; 2013 Sep; 96(3):962-8. PubMed ID: 23932319 [TBL] [Abstract][Full Text] [Related]
22. Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer. Tian D; Pei Y; Zheng Q; Zhang J; Li S; Wang X; Lin D; Yang Y Thorac Cancer; 2017 Mar; 8(2):97-105. PubMed ID: 28256095 [TBL] [Abstract][Full Text] [Related]
23. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer. Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585 [TBL] [Abstract][Full Text] [Related]
24. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer. Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087 [TBL] [Abstract][Full Text] [Related]
25. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection. Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381 [TBL] [Abstract][Full Text] [Related]
26. Involvement of FoxM1 in non-small cell lung cancer recurrence. Xu N; Wu SD; Wang H; Wang Q; Bai CX Asian Pac J Cancer Prev; 2012; 13(9):4739-43. PubMed ID: 23167412 [TBL] [Abstract][Full Text] [Related]
27. High expression of CHRNA1 is associated with reduced survival in early stage lung adenocarcinoma after complete resection. Chang PM; Yeh YC; Chen TC; Wu YC; Lu PJ; Cheng HC; Lu HJ; Chen MH; Chou TY; Huang CY Ann Surg Oncol; 2013 Oct; 20(11):3648-54. PubMed ID: 23775407 [TBL] [Abstract][Full Text] [Related]
29. Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer. Yan X; Jiao SC; Zhang GQ; Guan Y; Wang JL Cancer Gene Ther; 2017 Feb; 24(2):57-63. PubMed ID: 28084319 [TBL] [Abstract][Full Text] [Related]
30. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected. Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187 [TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of TAZ expression in resected non-small cell lung cancer. Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233 [TBL] [Abstract][Full Text] [Related]
32. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer. Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701 [TBL] [Abstract][Full Text] [Related]
33. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer. Liu K; Chen HL; Gu MM; You QS Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885 [TBL] [Abstract][Full Text] [Related]
34. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance. Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853 [TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of vascular and lymphovascular invasion in early lung cancer. Al-Alao BS; Gately K; Nicholson S; McGovern E; Young VK; O'Byrne KJ Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):55-64. PubMed ID: 24585645 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China. Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197 [TBL] [Abstract][Full Text] [Related]
37. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer. Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115 [TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [TBL] [Abstract][Full Text] [Related]
39. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519 [TBL] [Abstract][Full Text] [Related]
40. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer. Liu K; Chen HL; Gu MM; You QS Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]